{
    "paper_id": "3154d7ce830477990a00524a75897e8f49dd580f",
    "metadata": {
        "title": "Journal Pre-proof Revisi\u00f3n Narrativa Sobre La Respuesta Inmunitaria Frente A Coronavirus: Descripci\u00f3n General, Aplicabilidad Para Sars-Cov2 E Implicaciones Terap\u00e9uticas E-APPENDED REVISI\u00d3N NARRATIVA SOBRE LA RESPUESTA INMUNITARIA FRENTE A CORONAVIRUS: DESCRIPCI\u00d3N GENERAL, APLICABILIDAD PARA SARS-COV2 E IMPLICACIONES TERAP\u00c9UTICAS T\u00edtulo abreviado: Inmunidad y coronavirus",
        "authors": [
            {
                "first": "Alberto",
                "middle": [],
                "last": "Garc\u00eda-Salido",
                "suffix": "",
                "affiliation": {
                    "laboratory": "Servicio de Cuidados Intensivos Pedi\u00e1tricos. Hospital Infantil Universitario Ni\u00f1o Jes\u00fas. Madrid",
                    "institution": "",
                    "location": {
                        "country": "Espa\u00f1a"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "El nuevo coronavirus (SARS-CoV2) productor de s\u00edndrome respiratorio agudo severo surge en Wuhan en diciembre de 2019. Genera la denominada enfermedad por coronavirus 2019 (COVID-19) y ha llevado a la declaraci\u00f3n de emergencia de salud p\u00fablica global a la Organizaci\u00f3n Mundial de la Salud.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Page 2 of 17 J o u r n a l P r e -p r o o f 2 Este nuevo virus SARS-CoV2 podr\u00eda compartir caracter\u00edsticas y respuesta inmune a las descritas para otros coronavirus. Dada su actividad sobre la v\u00eda del interfer\u00f3n y el modo en el que disregula la inmunidad innata el uso de tratamientos dirigidos a modular o contener \u00e9sta pueden ser de inter\u00e9s. Se realiza una revisi\u00f3n narrativa de la evidencia actual acerca de la inmunidad sobre coronavirus y su aplicabilidad para SARS-CoV2. Se describe tambi\u00e9n la fisiopatogenia y la actividad leucocitaria subyacente con intenci\u00f3n de clarificar la posible utilidad de biomarcadores inflamatorios y el desarrollo de tratamientos personalizados. Palabras clave: Coronavirus; SARSCOV2; COVID19; inmunidad NARRATIVE REVIEW OF THE IMMUNE RESPONSE AGAINST CORONAVIRUS: AN OVERVIEW, APPLICABILITY FOR SARS-COV2, AND THERAPEUTIC IMPLICATIONS The new coronavirus (SARS-CoV2) that causes a severe acute respiratory syndrome emerged in Wuhan, China, in December 2019. It produces the aforementioned disease due to coronavirus 2019 (COVID-19), and has led to a declaration of a world public health emergency by the World Health Organisation.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "This new SARS-CoV2 virus could share characteristics and an immune response similar to those described for other coronavirus. Given its activity on the interferon pathway, and the manner in which it dysregulates innate immunity, the use of treatments directed at modulating or containing this could be Page 3 of 17 J o u r n a l P r e -p r o o f 3 of interest. A narrative review was made of the current evidence about immunity against coronavirus and it applicability to SARS-CoV2. The physiopathogenesis is also described, along with the underlying leucocyte activity, with the intention of clarifying the possible usefulness of inflammatory biomarkers and the development of personalised treatments.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "El nuevo coronavirus (SARS-CoV2) productor de s\u00edndrome respiratorio agudo severo surge en Wuhan en diciembre de 2019. Genera la denominada enfermedad por coronavirus 2019 (COVID-19) y ha llevado a la declaraci\u00f3n de emergencia de salud p\u00fablica global a la Organizaci\u00f3n Mundial de la Salud (OMS) 1 . En el momento de redactar este texto se encuentra declarada la pandemia por este virus y se han superado los 1850000 casos confirmados y 19500 fallecimientos en Espa\u00f1a 2 .",
            "cite_spans": [
                {
                    "start": 294,
                    "end": 295,
                    "text": "1",
                    "ref_id": "BIBREF0"
                }
            ],
            "ref_spans": [],
            "section": "Introducci\u00f3n"
        },
        {
            "text": "Hasta el momento actual, se ha descrito que COVID-19 muestra mayor prevalencia y gravedad en varones de edad avanzada y con presencia de comorbilidades (hipertensi\u00f3n arterial, diabetes mellitus tipo 1 o enfermedades cardiovasculares) [3] [4] [5] . Se ha teorizado sobre este hecho desde varias perspectivas.",
            "cite_spans": [
                {
                    "start": 234,
                    "end": 237,
                    "text": "[3]",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 238,
                    "end": 241,
                    "text": "[4]",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 242,
                    "end": 245,
                    "text": "[5]",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Introducci\u00f3n"
        },
        {
            "text": "Una de ellas es la inmunitaria, que parte de la presunci\u00f3n de una respuesta inadecuada e insuficiente por parte de un individuo con un sistema inmunitario previamente debilitado. As\u00ed, respuestas dependientes tanto de la inmunidad innata como adaptativa podr\u00edan tener un efecto delet\u00e9reo sobre la evoluci\u00f3n [6] [7] . Si bien es cierto que la fisiopatogenia de COVID-19 no se ha descrito completamente, epidemias previas por otros coronavirus podr\u00edan sustentar hip\u00f3tesis de comportamiento o anticipar respuestas inmunes 6-8 . As\u00ed, tanto en el s\u00edndrome respiratorio agudo (SARS, producido por SARS-CoV) como el s\u00edndrome respiratorio del oriente medio (MERS, producido por MERS-CoV) se caracterizaron por acompa\u00f1arse de respuesta inmunitarias asociadas a cantidades elevadas de citocinas proinflamatorias 6-9-10 . Ambos cuadros mostraron inflamaci\u00f3n pulmonar, da\u00f1o pulmonar extenso y desarrollo de s\u00edndrome de distress respiratorio 11 . Tambi\u00e9n a\u00f1adieron s\u00edndrome activaci\u00f3n macrof\u00e1gica y disregulaci\u00f3n inmune 6-7-12-13 .",
            "cite_spans": [
                {
                    "start": 306,
                    "end": 309,
                    "text": "[6]",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 310,
                    "end": 313,
                    "text": "[7]",
                    "ref_id": null
                },
                {
                    "start": 518,
                    "end": 523,
                    "text": "6-8 .",
                    "ref_id": null
                },
                {
                    "start": 801,
                    "end": 807,
                    "text": "6-9-10",
                    "ref_id": null
                },
                {
                    "start": 928,
                    "end": 930,
                    "text": "11",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Introducci\u00f3n"
        },
        {
            "text": "En este texto se realiza una revisi\u00f3n narrativa de la literatura existente sobre coronavirus, SARS-CoV-2 y sistema inmunitario. Se realiza una b\u00fasqueda estructurada de art\u00edculos indexados en Pubmed. Se utilizan los criterios MESH \"coronavirus\", \"inmunity\" y \"cytokines\". Dado el escaso n\u00famero de resultados se aplican los siguientes t\u00e9rminos de forma combinada: SARS-CoV2, COVID-19 e \"inmunity\", \"therapy\" y \"prognosis\". La b\u00fasqueda con art\u00edculos publicados se realiza hasta el 6 de abril de 2020.Tras esto se descartan gu\u00edas cl\u00ednicas y trabajos en cuyo abstract no se haga referencia a los datos vinculados al objetivo de la revisi\u00f3n. Se incluyen art\u00edculos en ingl\u00e9s.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Introducci\u00f3n"
        },
        {
            "text": "Los coronavirus son virus envueltos, no segmentados, y con ARN monocatenario en un tama\u00f1o que var\u00eda de 26 a 32 kilobases. Pertenecen a la familia Coronaviridae y al orden Nidovirales. Se encuentran ampliamente distribuidos en humanos y otros mam\u00edferos. Aunque en la mayor\u00eda de los de los casos las infecciones por coronavirus son leves, las epidemias por SARS-Cov y MERS-Cov causaron una mortalidad de aproximadamente 10 000 casos en las pasadas dos d\u00e9cadas. La tasa de mortalidad de SARS es del 10% y de MERS de hasta el 37% 6-10-14 .",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Coronavirus: caracter\u00edsticas y antecedentes."
        },
        {
            "text": "El virus SARS-CoV2 produce de forma generalizada cl\u00ednica catarral o leve requiriendo hasta en un 15-20% de los enfermos asistencia hospitalaria. Muestra adem\u00e1s una elevada transmisibilidad cuya comprensi\u00f3n no se encuentra completamente establecida 4-5-15-16 . S\u00ed es probable su contagio asintom\u00e1tico 17 . Esto \u00faltimo, deriva del uso de modelos matem\u00e1ticos aplicados en otros contextos ya demostrados. As\u00ed para el SARS-CoV se admite un 5% de contagios por asintom\u00e1ticos o para influenza Page 5 of 17 J o u r n a l P r e -p r o o f 5 H1N1 un 40% 6 . Al tiempo, parece que la contagiosidad de este nuevo virus supera a SARS y MERS actuando esto como evidente facilitador de la pandemia [18] [19] .",
            "cite_spans": [
                {
                    "start": 248,
                    "end": 257,
                    "text": "4-5-15-16",
                    "ref_id": null
                },
                {
                    "start": 300,
                    "end": 302,
                    "text": "17",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 683,
                    "end": 687,
                    "text": "[18]",
                    "ref_id": null
                },
                {
                    "start": 688,
                    "end": 692,
                    "text": "[19]",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Coronavirus: caracter\u00edsticas y antecedentes."
        },
        {
            "text": "Finalmente, dada la similitud del genoma de SARS-CoV2 con el del SARS, se ha establecido como un probable receptor celular para SARS-CoV2 la enzima convertidora de angiotensina 2 (ACE2). En el momento actual se desconoce si este supone el \u00fanico receptor siendo probable la existencia de otros. La enzima ACE2, se encuentra en otras especies animales (salvo ratas y ratones) 14 . Esto justificar\u00eda primero el contagio de vector animal a humano y, posteriormente, de humano a humano 19 .",
            "cite_spans": [
                {
                    "start": 374,
                    "end": 376,
                    "text": "14",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 481,
                    "end": 483,
                    "text": "19",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Coronavirus: caracter\u00edsticas y antecedentes."
        },
        {
            "text": "El modo primario de infecci\u00f3n es la transmisi\u00f3n de persona a persona a trav\u00e9s del contacto cercano, que ocurre mediante la pulverizaci\u00f3n de gotas de individuos infectados a trav\u00e9s de su tos o estornudos 18 La respuesta ante infecci\u00f3n por coronavirus depende tanto de la disponibilidad de receptores libres ACE2, para lo cual la presencia de formas solubles del mismo podr\u00eda influir, como respuesta de la inmunidad innata puesta en marcha por el hu\u00e9sped. En el caso de las infecciones virales, \u00e9sta a su vez se encuentra ligada a las respuestas interfer\u00f3n tipo I (IFN). Para generar una respuesta antiviral, las c\u00e9lulas de la inmunidad innata reconocen el virus mediante patrones moleculares asociados a pat\u00f3genos (PAMP) 14 . Para un virus ARN como el SARS-CoV-2, el ARN gen\u00f3mico viral o los productos intermedios de la replicaci\u00f3n viral participan en este fen\u00f3meno 6 .",
            "cite_spans": [
                {
                    "start": 203,
                    "end": 205,
                    "text": "18",
                    "ref_id": null
                },
                {
                    "start": 720,
                    "end": 722,
                    "text": "14",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 865,
                    "end": 866,
                    "text": "6",
                    "ref_id": "BIBREF6"
                }
            ],
            "ref_spans": [],
            "section": "Transmisi\u00f3n, sistema inmunitario y SARS-CoV2"
        },
        {
            "text": "La activaci\u00f3n de la v\u00eda del IFN limita la replicaci\u00f3n viral e induce la posterior respuesta inmune adaptativa. Como se indic\u00f3, el SARS-CoV y el SARS-CoV-2 parecen compartir como receptor la enzima convertidora de angiotensina 2 (ACE2). Este receptor propuesto para SARS-CoV-2 se expresa principalmente en las c\u00e9lulas alveolares tipo 2 del pulm\u00f3n [21] [22] [23] . Los receptores ACE2 tambi\u00e9n se encuentran en monocitos, macr\u00f3fagos o c\u00e9lulas endoteliales habi\u00e9ndose descrito tambi\u00e9n neurotropismo 7 Los coronavirus est\u00e1n particularmente adaptados para evadir la detecci\u00f3n inmune. Durante las distintas epidemias de SARS-CoV y el MERS-CoV este hecho fue muy estudiado. La interferencia en el reconocimiento de interfer\u00f3n, el cross-talking intercelular y la se\u00f1alizaci\u00f3n intracelular suponen los tres modos fundamentales para lograr evadir la actividad inmunitaria 6 .",
            "cite_spans": [
                {
                    "start": 346,
                    "end": 350,
                    "text": "[21]",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 351,
                    "end": 355,
                    "text": "[22]",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 356,
                    "end": 360,
                    "text": "[23]",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Inmunidad innata frente a SARS-CoV-2"
        },
        {
            "text": "Desde la perspectiva leucocitaria, los coronavirus infectan de forma primaria a macr\u00f3fagos. Estos presentan los ant\u00edgenos sobre las c\u00e9lulas T lo que provoca su activaci\u00f3n y la producci\u00f3n de citoquinas asociadas a los diferentes subtipos de estos (destacando el tipo Th17). Posteriormente estas citoquinas amplificaran la respuesta inmune 14 .",
            "cite_spans": [
                {
                    "start": 338,
                    "end": 340,
                    "text": "14",
                    "ref_id": "BIBREF20"
                }
            ],
            "ref_spans": [],
            "section": "Inmunidad innata frente a SARS-CoV-2"
        },
        {
            "text": "Como se ha indicado, la producci\u00f3n de IFN tipo I es de gran importancia con intenci\u00f3n de optimizar la liberaci\u00f3n de prote\u00ednas antivirales, promover la fagocitosis por macr\u00f3fagos y facilitar la protecci\u00f3n de c\u00e9lulas no infectadas. Las prote\u00ednas accesorias de los coronavirus pueden interferir la se\u00f1alizaci\u00f3n v\u00eda PAMP de los receptores de tipo toll (Toll-like receptors o TLR) durante la replicaci\u00f3n para evitar as\u00ed la activaci\u00f3n 14 .",
            "cite_spans": [
                {
                    "start": 429,
                    "end": 431,
                    "text": "14",
                    "ref_id": "BIBREF20"
                }
            ],
            "ref_spans": [],
            "section": "Inmunidad innata frente a SARS-CoV-2"
        },
        {
            "text": "Dicha interferencia deriva en dos hechos. Por un lado, se facilita la persistencia viral. Por otro se genera un efecto negativo en c\u00e9lulas natural killer (NK) o macr\u00f3fagos y se altera la activaci\u00f3n de las c\u00e9lulas T CD8+. La respuesta innata se ve disregulada. Ambos fen\u00f3menos en conjunto se pueden acompa\u00f1ar de una producci\u00f3n inadecuada de citoquinas condicionando un contexto proinflamatorio 19 . De este modo la s\u00edntesis de IL-1, IL-6, IL-8, IL-21, factor de necrosis tumoral beta (TNF-\u03b2) y prote\u00edna quimioatrayente de monocitos 1 (MCP-1) provoca el reclutamiento de linfocitos y leucocitos en el lugar de infecci\u00f3n, lo que dinamizar\u00eda el cuadro respiratorio 3-14-26-27 .",
            "cite_spans": [
                {
                    "start": 393,
                    "end": 395,
                    "text": "19",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Inmunidad innata frente a SARS-CoV-2"
        },
        {
            "text": "Seg\u00fan los datos publicados hasta el momento, una mayor\u00eda de pacientes con COVID19 y necesidad de ingreso hospitalario mostraron linfopenia 19 . Esto se justificar\u00eda, como se ha explicado, por la migraci\u00f3n a territorio pulmonar de linfocitos T. Al tiempo, las im\u00e1genes descritas en las radiograf\u00edas de t\u00f3rax y las tomograf\u00edas pulmonares como neumon\u00eda bilateral con im\u00e1genes en vidrio esmerilado constituir\u00edan la expresi\u00f3n cl\u00ednica de esto [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] . Dicha migraci\u00f3n linfocitaria, acompa\u00f1ada de forma fundamental por El observado s\u00edndrome de distress respiratorio ser\u00eda el reflejo \u00faltimo de esto 27 .",
            "cite_spans": [
                {
                    "start": 139,
                    "end": 141,
                    "text": "19",
                    "ref_id": null
                },
                {
                    "start": 437,
                    "end": 441,
                    "text": "[11]",
                    "ref_id": null
                },
                {
                    "start": 442,
                    "end": 446,
                    "text": "[12]",
                    "ref_id": null
                },
                {
                    "start": 447,
                    "end": 451,
                    "text": "[13]",
                    "ref_id": null
                },
                {
                    "start": 452,
                    "end": 456,
                    "text": "[14]",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 457,
                    "end": 461,
                    "text": "[15]",
                    "ref_id": null
                },
                {
                    "start": 462,
                    "end": 466,
                    "text": "[16]",
                    "ref_id": null
                },
                {
                    "start": 467,
                    "end": 471,
                    "text": "[17]",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 472,
                    "end": 476,
                    "text": "[18]",
                    "ref_id": null
                },
                {
                    "start": 477,
                    "end": 481,
                    "text": "[19]",
                    "ref_id": null
                },
                {
                    "start": 482,
                    "end": 486,
                    "text": "[20]",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 487,
                    "end": 491,
                    "text": "[21]",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 492,
                    "end": 496,
                    "text": "[22]",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 497,
                    "end": 501,
                    "text": "[23]",
                    "ref_id": null
                },
                {
                    "start": 502,
                    "end": 506,
                    "text": "[24]",
                    "ref_id": null
                },
                {
                    "start": 507,
                    "end": 511,
                    "text": "[25]",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 512,
                    "end": 516,
                    "text": "[26]",
                    "ref_id": null
                },
                {
                    "start": 517,
                    "end": 521,
                    "text": "[27]",
                    "ref_id": null
                },
                {
                    "start": 669,
                    "end": 671,
                    "text": "27",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Patr\u00f3n de respuesta inmune a coronavirus SARS -CoV2, conocimiento actual"
        },
        {
            "text": "En relaci\u00f3n a las poblaciones leucocitarias, y dada la linfopenia, se ha propuesto el ratio neutr\u00f3filolinfocito como un posible marcador de evoluci\u00f3n. Cuanto mayor sea este, m\u00e1s riesgo de empeoramiento.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Patr\u00f3n de respuesta inmune a coronavirus SARS -CoV2, conocimiento actual"
        },
        {
            "text": "El descenso relativo de linfocitos ser\u00eda un marcador indirecto de la inflamaci\u00f3n pulmonar subyacente 3-",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Patr\u00f3n de respuesta inmune a coronavirus SARS -CoV2, conocimiento actual"
        },
        {
            "text": "En trabajos ya publicados en pacientes COVID19 hospitalizados con mala evoluci\u00f3n, se han descrito niveles de citocinas aumentados. As\u00ed se describe elevaci\u00f3n de IL-2, IL-7, IL-10, G-CSF, IP-10, MCP-1, MIP-1A y TNF\u03b1 29 . Estos hallazgos se alinean con lo visto en las epidemias de SARS y MERS. En ambas tanto la linfopenia como la denominada \"tormenta de citoquinas\" fueron fundamentales en la patog\u00e9nesis. Tambi\u00e9n se ha descrito un aumento de d\u00edmero D, troponina I, IL-6 en suero y de prote\u00edna C reactiva 3-5-7-14-15 . En relaci\u00f3n a la IL-6, \u00e9sta es producida por macr\u00f3fagos, c\u00e9lulas T, c\u00e9lulas endoteliales y fibroblastos. Como se ha indicado con anterioridad tanto c\u00e9lulas T como macr\u00f3fagos tienen un papel fundamental en la instauraci\u00f3n de la inmunidad innata frente a coronavirus. La expresi\u00f3n exacerbada de IL-6 no solo condiciona un estado proinflamatorio. Al tiempo indica una activaci\u00f3n de aquellas poblaciones que la producen, como son los macr\u00f3fagos. Se han descrito tanto en el caso de MERS-Cov como SARS-Cov fen\u00f3menos de activaci\u00f3n macrof\u00e1gica [6] [7] [8] [9] [10] [11] [12] [13] [14] . Dicha situaci\u00f3n, dados los datos disponibles hasta el momento, podr\u00eda tener tambi\u00e9n importancia en el pron\u00f3stico y respuesta a la infecci\u00f3n por SARS-Cov2 3 .",
            "cite_spans": [
                {
                    "start": 1055,
                    "end": 1058,
                    "text": "[6]",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 1059,
                    "end": 1062,
                    "text": "[7]",
                    "ref_id": null
                },
                {
                    "start": 1063,
                    "end": 1066,
                    "text": "[8]",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 1067,
                    "end": 1070,
                    "text": "[9]",
                    "ref_id": null
                },
                {
                    "start": 1071,
                    "end": 1075,
                    "text": "[10]",
                    "ref_id": null
                },
                {
                    "start": 1076,
                    "end": 1080,
                    "text": "[11]",
                    "ref_id": null
                },
                {
                    "start": 1081,
                    "end": 1085,
                    "text": "[12]",
                    "ref_id": null
                },
                {
                    "start": 1086,
                    "end": 1090,
                    "text": "[13]",
                    "ref_id": null
                },
                {
                    "start": 1091,
                    "end": 1095,
                    "text": "[14]",
                    "ref_id": "BIBREF20"
                }
            ],
            "ref_spans": [],
            "section": "17-28 ."
        },
        {
            "text": "Desde un punto de vista histopatol\u00f3gico, y como consecuencia de lo comentado, ser\u00edan esperables en COVID19 cambios semejantes a los observados en la epidemia por SARS-Cov 30 . As\u00ed los pulmones de pacientes afectados mostraron tanto respuestas inflamatorias inespec\u00edficas como edema e infiltraci\u00f3n celular [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] . Se a\u00f1ad\u00eda a esto descamaci\u00f3n severa de c\u00e9lulas epiteliales alveolares, ensanchamiento septal alveolar, da\u00f1o a los tabiques alveolares e infiltraci\u00f3n del espacio alveolar. Dicha inflamaci\u00f3n conduc\u00eda con posterioridad a necrosis, infiltraci\u00f3n e hiperplasia [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] .",
            "cite_spans": [
                {
                    "start": 305,
                    "end": 309,
                    "text": "[11]",
                    "ref_id": null
                },
                {
                    "start": 310,
                    "end": 314,
                    "text": "[12]",
                    "ref_id": null
                },
                {
                    "start": 315,
                    "end": 319,
                    "text": "[13]",
                    "ref_id": null
                },
                {
                    "start": 320,
                    "end": 324,
                    "text": "[14]",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 325,
                    "end": 329,
                    "text": "[15]",
                    "ref_id": null
                },
                {
                    "start": 330,
                    "end": 334,
                    "text": "[16]",
                    "ref_id": null
                },
                {
                    "start": 335,
                    "end": 339,
                    "text": "[17]",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 340,
                    "end": 344,
                    "text": "[18]",
                    "ref_id": null
                },
                {
                    "start": 345,
                    "end": 349,
                    "text": "[19]",
                    "ref_id": null
                },
                {
                    "start": 350,
                    "end": 354,
                    "text": "[20]",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 355,
                    "end": 359,
                    "text": "[21]",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 360,
                    "end": 364,
                    "text": "[22]",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 365,
                    "end": 369,
                    "text": "[23]",
                    "ref_id": null
                },
                {
                    "start": 370,
                    "end": 374,
                    "text": "[24]",
                    "ref_id": null
                },
                {
                    "start": 375,
                    "end": 379,
                    "text": "[25]",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 380,
                    "end": 384,
                    "text": "[26]",
                    "ref_id": null
                },
                {
                    "start": 385,
                    "end": 389,
                    "text": "[27]",
                    "ref_id": null
                },
                {
                    "start": 647,
                    "end": 651,
                    "text": "[13]",
                    "ref_id": null
                },
                {
                    "start": 652,
                    "end": 656,
                    "text": "[14]",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 657,
                    "end": 661,
                    "text": "[15]",
                    "ref_id": null
                },
                {
                    "start": 662,
                    "end": 666,
                    "text": "[16]",
                    "ref_id": null
                },
                {
                    "start": 667,
                    "end": 671,
                    "text": "[17]",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 672,
                    "end": 676,
                    "text": "[18]",
                    "ref_id": null
                },
                {
                    "start": 677,
                    "end": 681,
                    "text": "[19]",
                    "ref_id": null
                },
                {
                    "start": 682,
                    "end": 686,
                    "text": "[20]",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 687,
                    "end": 691,
                    "text": "[21]",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 692,
                    "end": 696,
                    "text": "[22]",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 697,
                    "end": 701,
                    "text": "[23]",
                    "ref_id": null
                },
                {
                    "start": 702,
                    "end": 706,
                    "text": "[24]",
                    "ref_id": null
                },
                {
                    "start": 707,
                    "end": 711,
                    "text": "[25]",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 712,
                    "end": 716,
                    "text": "[26]",
                    "ref_id": null
                },
                {
                    "start": 717,
                    "end": 721,
                    "text": "[27]",
                    "ref_id": null
                },
                {
                    "start": 722,
                    "end": 726,
                    "text": "[28]",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 727,
                    "end": 731,
                    "text": "[29]",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "17-28 ."
        },
        {
            "text": "En el momento actual el tratamiento de COVID19 se basa eminentemente en el control de los s\u00edntomas y el abordaje respiratorio acorde a las necesidades del paciente 31 . En determinados pacientes, como son aquellos con factores de riesgo o mala evoluci\u00f3n, se plantea el uso emp\u00edrico de diversos f\u00e1rmacos dirigidos tanto contra el virus como para condicionar una respuesta inmunitaria disregulada. Se realiza a continuaci\u00f3n una breve descripci\u00f3n de todos ellos.",
            "cite_spans": [
                {
                    "start": 164,
                    "end": 166,
                    "text": "31",
                    "ref_id": "BIBREF47"
                }
            ],
            "ref_spans": [],
            "section": "Tratamientos"
        },
        {
            "text": "El uso de ambos antivirales se plantea en COVID19 como resultado de su anterior utilidad frente a SARS-CoV y MERS-Cov. No existe evidencia actual que sustente su uso y los primeros trabajos realizados indican que puede no tener influencia sobre la mortalidad de estos pacientes 32 .",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Lopinavir/ritonavir"
        },
        {
            "text": "Este f\u00e1rmaco posee actividad antiviral frente a un n\u00famero amplio de virus ARN entre los que se incluyen SARS-CoV y MERS-CoV 6-9-33 . En el momento actual se estudia su utilidad terap\u00e9utica frente al \u00c9bola.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Remdesivir"
        },
        {
            "text": "Su efecto y utilidad frente a SARS-CoV2 se encuentra en estudio 33 .",
            "cite_spans": [
                {
                    "start": 64,
                    "end": 66,
                    "text": "33",
                    "ref_id": "BIBREF52"
                }
            ],
            "ref_spans": [],
            "section": "Remdesivir"
        },
        {
            "text": "La posible utilidad de la hidroxicloroquina (HQ) frente a coronavirus ya fue descrita en la epidemia por SARS-CoV. Dicha mol\u00e9cula alcaliniza el medio dificultando la acci\u00f3n del fagolisosoma viral y, por lo tanto, enlentece o dificulta la replicaci\u00f3n de coronavirus. Recientemente se ha demostrado su utilidad in vitro contra el SARS-CoV-2 34 . Dicha utilidad a\u00fan no dispone de evidencia cl\u00ednica siendo por lo tanto su uso emp\u00edrico 35 . Se debe prestar atenci\u00f3n a los posibles efectos secundarios ya sea en administraci\u00f3n individual o en combinaci\u00f3n con otros f\u00e1rmacos [36] [37] .",
            "cite_spans": [
                {
                    "start": 339,
                    "end": 341,
                    "text": "34",
                    "ref_id": null
                },
                {
                    "start": 431,
                    "end": 433,
                    "text": "35",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 568,
                    "end": 572,
                    "text": "[36]",
                    "ref_id": null
                },
                {
                    "start": 573,
                    "end": 577,
                    "text": "[37]",
                    "ref_id": "BIBREF58"
                }
            ],
            "ref_spans": [],
            "section": "Hidroxicloroquina"
        },
        {
            "text": "Se atribuye a este grupo de antibi\u00f3ticos cierto perfil inmunomodulador. De este modo parece que poseen cierto papel sobre la acci\u00f3n de neutr\u00f3filos o la liberaci\u00f3n de citoquinas como IL-8. Se ha visto demostrada su posible utilidad en neumon\u00edas virales y, por extensi\u00f3n, se ha planteado como tratamiento adyuvante ante COVID19. No existe a\u00fan evidencia que confirme que su uso individual o en combinaci\u00f3n con HQ permita una mejor evoluci\u00f3n 36 .",
            "cite_spans": [
                {
                    "start": 438,
                    "end": 440,
                    "text": "36",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Macr\u00f3lidos"
        },
        {
            "text": "Interferon alfa y beta la posible disrupci\u00f3n que en esta v\u00eda de respuesta innata produce el virus. Bajo este mismo criterio se utiliz\u00f3 en anteriores epidemias por coronavirus ofreciendo resultados controvertidos.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Macr\u00f3lidos"
        },
        {
            "text": "El uso de corticoterapia en el paciente con COVID19 resulta discutido. Por un lado, se obtiene de su aplicaci\u00f3n un efecto inmunosupresor que ante una disregulaci\u00f3n inmune proinflamatoria pudiera ser \u00fatil [30] [31] [32] [33] [34] [35] [36] [37] [38] . Por otro lado, estos f\u00e1rmacos incrementan y perpet\u00faan la linfopenia pudiendo interferir en una respuesta dirigida a aclarar la presencia viral. En la enfermedad respiratoria provocada por SARS-CoV su uso no aport\u00f3 beneficios e incluso se asoci\u00f3 a una mayor persistencia de la viremia.",
            "cite_spans": [
                {
                    "start": 204,
                    "end": 208,
                    "text": "[30]",
                    "ref_id": null
                },
                {
                    "start": 209,
                    "end": 213,
                    "text": "[31]",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 214,
                    "end": 218,
                    "text": "[32]",
                    "ref_id": null
                },
                {
                    "start": 219,
                    "end": 223,
                    "text": "[33]",
                    "ref_id": "BIBREF52"
                },
                {
                    "start": 224,
                    "end": 228,
                    "text": "[34]",
                    "ref_id": null
                },
                {
                    "start": 229,
                    "end": 233,
                    "text": "[35]",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 234,
                    "end": 238,
                    "text": "[36]",
                    "ref_id": null
                },
                {
                    "start": 239,
                    "end": 243,
                    "text": "[37]",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 244,
                    "end": 248,
                    "text": "[38]",
                    "ref_id": "BIBREF59"
                }
            ],
            "ref_spans": [],
            "section": "Corticoides"
        },
        {
            "text": "Las recomendaciones realizadas por los cl\u00ednicos que atendieron COVID19 en Wuhan pivotan sobre cinco claves: (1) Se debe el valorar cuidadosamente el beneficio/riesgo de su uso (2) Se deben considerar sobre todo en pacientes cr\u00edticos (3) En pacientes con hipoxemia debido a enfermedades subyacentes o con tratamiento con corticoides de forma regular debe considerarse su uso (4) Las dosis deben ser bajas o moderadas (\u2264 0,5-1 mg/ kg por d\u00eda de metilprednisolona o equivalente) y (5) la duraci\u00f3n debe ser corta (\u22647 d\u00edas) 39 .",
            "cite_spans": [
                {
                    "start": 519,
                    "end": 521,
                    "text": "39",
                    "ref_id": "BIBREF60"
                }
            ],
            "ref_spans": [],
            "section": "Corticoides"
        },
        {
            "text": "Como se ha comentado la s\u00edntesis de IL-6 por parte de macr\u00f3fagos y linfocitos T forma parte de la respuesta inmunitaria realizada frente a SARS-CoV2. En el caso de mostrar evoluci\u00f3n t\u00f3rpida o empeoramiento cl\u00ednico, parece frecuente objetivarse un valor elevado de esta citoquina en el torrente sangu\u00edneo. Tocilizumab es anticuerpo monoclonal humanizado dirigido contra el receptor de la IL-6. Su uso podr\u00eda frenar la activaci\u00f3n inmunitaria subyacente siendo por lo tanto una opci\u00f3n terap\u00e9utica en pacientes con cr\u00edtica o mala evoluci\u00f3n. En el caso de no disponer de la determinaci\u00f3n de esta mol\u00e9cula se puede utilizar como biomarcador la ferritina 12-19-31-38 . En el momento actual la ferritina posee una sensibilidad y especificidad adecuada como herramienta de diagn\u00f3stico y seguimiento del s\u00edndrome de activaci\u00f3n macrof\u00e1gica 29 .",
            "cite_spans": [
                {
                    "start": 829,
                    "end": 831,
                    "text": "29",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Tocilizumab"
        },
        {
            "text": "Planteado su uso en epidemias previas por SARS-CoV y MERS-CoV en el momento actual existen pocos datos acerca de su beneficio. Solo un trabajo sobre cinco pacientes parece ofrecer resultados.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Suero de convaleciente"
        },
        {
            "text": "Debe ser valorado su uso con precauci\u00f3n dado que el mismo puede no estar exento de riesgos 40 .",
            "cite_spans": [
                {
                    "start": 91,
                    "end": 93,
                    "text": "40",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Suero de convaleciente"
        },
        {
            "text": "En conclusi\u00f3n, SARS-CoV2 podr\u00eda compartir caracter\u00edsticas y respuesta inmune semejantes a las mostradas por otros coronavirus con anterioridad. Dada su actividad sobre la v\u00eda del interfer\u00f3n y el modo en el que disregula la inmunidad innata el uso de tratamientos dirigidos a modular o contener \u00e9sta pueden ser de inter\u00e9s. El conocimiento de la fisiopatogenia subyacente o la determinaci\u00f3n de determinados biomarcadores (linfocitos o niveles de IL-6) podr\u00edan ser una herramienta \u00fatil para anticipar la evoluci\u00f3n y practicar un tratamiento dirigido y personalizado.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Suero de convaleciente"
        },
        {
            "text": "A todo el personal sanitario que en esta terrible situaci\u00f3n est\u00e1 aportando y ayudando. A todos los que con muy poco hacen mucho m\u00e1s que demasiado. A los pacientes y sus familias.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Agradecimientos"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Khan",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Siddique",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Shereen",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ali",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Bai",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Bashir",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Xue",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Journal of clinical",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Situaci\u00f3n de COVID-19 en Espa\u00f1a, Ministerio de Sanidad",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Estimating Risk for Death from 2019 Novel Coronavirus Disease, China",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Mizumoto",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Chowell",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Emerging infectious diseases",
            "volume": "26",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "J"
                    ],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Dong",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "Y"
                    ],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "D"
                    ],
                    "last": "Yuan",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "B"
                    ],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "Q"
                    ],
                    "last": "Yan",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "A"
                    ],
                    "last": "Akdis",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "D"
                    ],
                    "last": "Gao",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "China. Allergy",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wei",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Tu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Lancet",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Prompetchara",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Ketloy",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Palaga",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Asian Pacific journal of allergy and immunology",
            "volume": "38",
            "issn": "",
            "pages": "1--9",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Ds",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Reducing mortality from 2019-nCoV: host-directed therapies should be an option",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Fowler",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "G"
                    ],
                    "last": "Hayden",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Zumla",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "S"
                    ],
                    "last": "Hui",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "I"
                    ],
                    "last": "Azhar",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "A"
                    ],
                    "last": "Memish",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Maeurer",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Intensive care medicine",
            "volume": "395",
            "issn": "",
            "pages": "35--41",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Coronavirus infections and immune responses",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Peeri",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "C"
                    ],
                    "last": "Shrestha",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Rahman",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "S"
                    ],
                    "last": "Zaki",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Tan",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Bibi",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Baghbanzadeh",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Journal of medical virology",
            "volume": "92",
            "issn": "",
            "pages": "424--456",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "The SARS, MERS and novel coronavirus",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Aghamohammadi",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Haque",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "epidemics, the newest and biggest global health threats: what lessons have we learned?",
            "authors": [],
            "year": 2020,
            "venue": "Int J Epidemiol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States. Emerging infectious diseases 2020;26. 12. Fan BE",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Sg",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Narayanan",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Makino",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "G"
                    ],
                    "last": "Ksiazek",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "S"
                    ],
                    "last": "Plante",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "C"
                    ],
                    "last": "Weaver",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lindstrom",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Tong",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "D"
                    ],
                    "last": "Menachery",
                    "suffix": ""
                },
                {
                    "first": "Nj ;",
                    "middle": [],
                    "last": "Thornburg",
                    "suffix": ""
                },
                {
                    "first": "Vcl",
                    "middle": [],
                    "last": "Chong",
                    "suffix": ""
                },
                {
                    "first": "Ssw",
                    "middle": [],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "H"
                    ],
                    "last": "Lim",
                    "suffix": ""
                },
                {
                    "first": "Kge",
                    "middle": [],
                    "last": "Lim",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "B"
                    ],
                    "last": "Tan",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "S"
                    ],
                    "last": "Mucheli",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Hematologic parameters in patients with COVID-19 infection",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Ong",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "H"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "American journal",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Chen",
                    "middle": [
                        "X"
                    ],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Lei",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Peng",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "Y"
                    ],
                    "last": "Du",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Annals of internal",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Coronavirus infections and immune responses",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zhong",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Xiao",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Cell research",
            "volume": "92",
            "issn": "",
            "pages": "424--456",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Clinical Characteristics of Coronavirus Disease 2019 in China. The New England journal of",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Du",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "J"
                    ],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Zeng",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "Y"
                    ],
                    "last": "Yuen",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "C"
                    ],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "L"
                    ],
                    "last": "Tang",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "Y"
                    ],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xiang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "Y"
                    ],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "J"
                    ],
                    "last": "Liang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "X"
                    ],
                    "last": "Peng",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Wei",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "H"
                    ],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Peng",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "Y"
                    ],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "J"
                    ],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "Q"
                    ],
                    "last": "Qiu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Luo",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Ye",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "Y"
                    ],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "S"
                    ],
                    "last": "Zhong",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Hn",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "F"
                    ],
                    "last": "Sheng",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "L"
                    ],
                    "last": "Cai",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "Q"
                    ],
                    "last": "Qiu",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "J"
                    ],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "Critical care management of adults with community-acquired severe respiratory viral infection",
            "authors": [
                {
                    "first": "Y",
                    "middle": [
                        "M"
                    ],
                    "last": "Arabi",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Clinical research ed)",
            "volume": "46",
            "issn": "",
            "pages": "315--343",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study",
            "authors": [
                {
                    "first": "C-Wg",
                    "middle": [],
                    "last": "Jit",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Klepac",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Mathematical Modelling of Infectious Diseases",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak -an update on the status",
            "authors": [],
            "year": 2020,
            "venue": "Mil Med Res",
            "volume": "7",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, China. The European respiratory",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "H"
                    ],
                    "last": "Gao",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "L"
                    ],
                    "last": "Lou",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "J"
                    ],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "SARS-CoV-2: a potential novel etiology of fulminant",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "W"
                    ],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? Clinical science",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Batlle",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wysocki",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Satchell",
                    "suffix": ""
                }
            ],
            "year": 1979,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms",
            "authors": [],
            "year": null,
            "venue": "Journal of medical virology 2020. 24. Baig AM",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "A potential role for integrins in host cell entry by SARS-CoV-2",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Sigrist",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Bridge",
                    "suffix": ""
                },
                {
                    "first": "Le",
                    "middle": [],
                    "last": "Mercier",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Antiviral research",
            "volume": "177",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Song",
                    "middle": [
                        "J"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Chao",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Xiong",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Bai",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Song",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "JAMA internal",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Mei",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [
                        "L"
                    ],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [
                        "H"
                    ],
                    "last": "Zeng",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "K"
                    ],
                    "last": "Egglin",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "F"
                    ],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Agarwal",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Xie",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Healey",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "K"
                    ],
                    "last": "Atalay",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "H"
                    ],
                    "last": "Liao",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Radiology",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "Critical Care Utilization for the COVID-19",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Grasselli",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Pesenti",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Cecconi",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF42": {
            "ref_id": "b42",
            "title": "Early Experience and Forecast During an Emergency Response",
            "authors": [],
            "year": 2020,
            "venue": "Jama",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Lin",
                    "middle": [
                        "Y"
                    ],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Shi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Lan",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Emerging microbes & infections",
            "volume": "9",
            "issn": "",
            "pages": "761--70",
            "other_ids": {}
        },
        "BIBREF46": {
            "ref_id": "b46",
            "title": "Pathological findings of COVID-19 associated with acute respiratory distress syndrome",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Bai",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Gao",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Song",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xia",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Dong",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "F-S",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "The Lancet Respiratory Medicine",
            "volume": "8",
            "issn": "",
            "pages": "420--422",
            "other_ids": {}
        },
        "BIBREF47": {
            "ref_id": "b47",
            "title": "Treatment of COVID-19: old tricks for new challenges",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Cunningham",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "P"
                    ],
                    "last": "Goh",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Koh",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Crit Care",
            "volume": "24",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF51": {
            "ref_id": "b51",
            "title": "A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Jaki",
                    "middle": [
                        "T"
                    ],
                    "last": "Hayden",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "G"
                    ],
                    "last": "Horby",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "W"
                    ],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "The New England journal",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF52": {
            "ref_id": "b52",
            "title": "Arguments in favour of remdesivir for treating SARS-CoV-2 infections",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "C"
                    ],
                    "last": "Ko",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Rolain",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "Y"
                    ],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "L"
                    ],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "T"
                    ],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "I"
                    ],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "R"
                    ],
                    "last": "Hsueh",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "International journal of antimicrobial agents",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF54": {
            "ref_id": "b54",
            "title": "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro",
            "authors": [],
            "year": 2020,
            "venue": "Cell research",
            "volume": "30",
            "issn": "",
            "pages": "269--71",
            "other_ids": {}
        },
        "BIBREF55": {
            "ref_id": "b55",
            "title": "A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Cortegiani",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Ingoglia",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ippolito",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Giarratano",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Einav",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Crit Care",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF57": {
            "ref_id": "b57",
            "title": "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Giordanengo",
                    "middle": [
                        "V"
                    ],
                    "last": "Vieira",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "E"
                    ],
                    "last": "Dupont",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "T"
                    ],
                    "last": "Honore",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Colson",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Chabriere",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "La",
                    "middle": [],
                    "last": "Scola",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Rolain",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Brouqui",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Raoult",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "International journal of antimicrobial agents",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF58": {
            "ref_id": "b58",
            "title": "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Shi",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Cell research",
            "volume": "30",
            "issn": "",
            "pages": "269--71",
            "other_ids": {}
        },
        "BIBREF59": {
            "ref_id": "b59",
            "title": "COVID-19: combining antiviral and anti-inflammatory treatments",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Stebbing",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Phelan",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Griffin",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Tucker",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Oechsle",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Smith",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Richardson",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "The Lancet Infectious",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF60": {
            "ref_id": "b60",
            "title": "On the use of corticosteroids for 2019-nCoV pneumonia",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Shang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Du",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "",
            "pages": "683--687",
            "other_ids": {}
        },
        "BIBREF63": {
            "ref_id": "b63",
            "title": "Treatment of 5 Critically Ill Patients With",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF64": {
            "ref_id": "b64",
            "title": "With Convalescent Plasma",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF1": {
            "text": ". La enfermedad por SARS-CoV2 tiene un per\u00edodo de incubaci\u00f3n asintom\u00e1tico probable entre 2 y 14 d\u00edas durante el cual se podr\u00eda transmitir el virus 20 . La r\u00e1pida propagaci\u00f3n de SARS-CoV-2 se ha producido con un \u00edndice de reproducci\u00f3n o R0 b\u00e1sico de 2.2-2.6. Esto significa que en promedio cada individuo tiene el potencial de transmitir la infecci\u00f3n a otras 2 o 3 personas 4-5-14-16-20 .",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "un da\u00f1o intersticial que a su vez repercutir\u00eda sobre el intercambio gaseoso y comprometer\u00eda le oxigenaci\u00f3n del paciente. Hipoxemia y disnea son dos datos prevalentes en COVID19.",
            "latex": null,
            "type": "figure"
        }
    },
    "back_matter": []
}